| Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections in K-12 schools and universities RP Mendoza, C Bi, HT Cheng, E Gabutan, GJ Pagaspas, N Khan, ... EClinicalMedicine 38, 2021 | 45 | 2021 |
| Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer RP Mendoza, T Haidary, E Gabutan, YY Zhou, Z Bukhari, C Connelly, ... Scientific Reports 11 (1), 14064, 2021 | 13 | 2021 |
| A dynamic Bayesian model for identifying high-mortality risk in hospitalized COVID-19 patients A Momeni-Boroujeni, R Mendoza, IJ Stopard, B Lambert, A Zuretti Infectious disease reports 13 (1), 239-250, 2021 | 13 | 2021 |
| Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19 R Mendoza, N Saha, A Momeni, E Gabutan, M Alawad, A Dehghani, ... Heliyon 7 (6), 2021 | 12 | 2021 |
| In vitro cytotoxic potential of Yacon (Smallanthus sonchifolius) against HT-29, MCF-7 and HDFn cell lines RP Mendoza, WS Vidar, GG Oyong Journal of Medicinal Plants Research 11 (10), 207-217, 2017 | 11 | 2017 |
| Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes RP Mendoza, W Fyke, D Daniel, E Gabutan, B Das, H Bajaj, M Easy, ... Human immunology 82 (4), 255-263, 2021 | 9 | 2021 |
| HLA B53 is associated with a poor outcome in black COVID-19 patients AJ Norin, R Mendoza, M Augenbraun, B Das Human Immunology 82 (10), 713-718, 2021 | 8 | 2021 |
| Correlation of automated chemiluminescent method with enzyme-linked immunosorbent assay (ELISA) antibody titers in convalescent COVID-19 plasma samples: development of rapid … R Mendoza, M Silver, AR Zuretti, M Christian, B Das, AJ Norin, P Borgen, ... Journal of blood medicine, 157-164, 2021 | 8 | 2021 |
| Endometrial carcinomas with subclonal loss of mismatch repair proteins: a clinicopathologic and genomic study RP Mendoza, P Wang, JJ Schulte, MY Tjota, I Jani, AC Martinez, ... The American Journal of Surgical Pathology 47 (5), 589-598, 2023 | 6 | 2023 |
| Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells N Saha, DS Baek, RP Mendoza, D Robev, Y Xu, Y Goldgur, ... Biomedicine & Pharmacotherapy 161, 114494, 2023 | 5 | 2023 |
| Primary epithelioid angiosarcoma of the breast: a rare and challenging biopsy diagnosis R Mendoza, K Loukeris The American Journal of Case Reports 20, 437, 2019 | 5 | 2019 |
| Clinicopathologic analysis and molecular profiling of ovarian steroid cell tumors RP Mendoza, P Wang, HL Smith, CA Fitzpatrick, R Haridas, P Wanjari, ... The American Journal of Surgical Pathology 47 (12), 1398-1408, 2023 | 2 | 2023 |
| Practical approach to the evaluation of malignant peritoneal fluids in the setting of gynecologic neoplasms RP Mendoza, RR Lastra Acta Cytologica 67 (2), 143-175, 2023 | 2 | 2023 |
| Low cost, injection molded, nasopharyngeal swabs for addressing global diagnostic supply shortages MR Martinez, R Mendoza, D Perry, E Gabutan, W Fyke, E Faber, SJ Saggi, ... MedRxiv, 2021.07. 19.21260235, 2021 | 2 | 2021 |
| PD-L1 expression, DNA mismatch repair genes, and HPV types in cervical squamous cell carcinoma. T Haidary, RP Mendoza, Y Zhou, WC Lee, YC Lee, R Gupta Journal of Clinical Oncology 37 (15_suppl), 5533-5533, 2019 | 2 | 2019 |
| Whole exome sequencing of placental chorangioma RP Mendoza, K Doytcheva, MU Dean, KM Jorgenson, D Choi, J Segal, ... Placenta 149, 13-17, 2024 | 1 | 2024 |
| Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization RP Mendoza, HIH Chen‐Yost, P Wanjari, P Wang, E Symes, DN Johnson, ... Cancer Medicine 13 (1), e6873, 2024 | 1 | 2024 |
| CTNNB1-mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma R Mendoza, E Kertowidjojo International Journal of Gynecological Pathology 42 (3), 325-326, 2023 | 1 | 2023 |
| Using patient biomarker time series to determine mortality risk in hospitalised COVID-19 patients: A comparative analysis across two New York hospitals B Lambert, IJ Stopard, A Momeni-Boroujeni, R Mendoza, A Zuretti Plos one 17 (8), e0272442, 2022 | 1 | 2022 |
| Uterine Inflammatory Myofibroblastic Tumors: p16 as a Surrogate for: CDKN2A: Deletion and Predictor of Aggressive Behavior KM Devins, Z Ordulu, RP Mendoza, S Croce, R Haridas, P Wanjari, ... The American Journal of Surgical Pathology 48 (7), 813-824, 2024 | | 2024 |
